Neuromodulation Review 1 (301)

9:15 AM–10:15 AM Saturday, February 29

In spite of significant advances in SCS technology, there is still a 20% failure rate in long term SCS therapy primarily due to loss of analgesic benefit. Participants will learn what physiological, pharmacological, and electromechanical factors may contribute to this failure rate and what steps can be implemented to improve long term SCS success.

Determinants of SCS Failures: Opioids, Lack of Sustained Analgesia, and SCS Tolerance/Adaptation

Peter Staats, MBA MD

Advances in SCS Pharmacology

Magdalena Anitescu, MD PhD

Programming Approaches to Solve Failure of SCS Analgesia

Lawrence Poree, MD MPH PhD

Learning Objectives:

  • Discuss physiological, pharmacological, and electromechanical factors that may contribute to a failure rate in long term SCS therapy.
  • Identify strategies to improve long-term SCS success.